Immunohistochemical expression of CRX in extracranial malignant small round cell tumors

American Journal of Surgical Pathology

Volumn 36, Issue 8, 2012, Pages 1165-1169

  Terry, Jefferson ^a   Calicchio, Monica L ^a   Rodriguez Galindo, Carlos ^a   Perez Atayde, Antonio R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

children; desmoplastic small round cell tumor; Ewing; malignant small round cell tumor; melanocytic neoplasm; neuroblastoma; PNET; retinoblastoma; rhabdomyosarcoma; Wilms tumor

Indexed keywords

CONE ROD HOMEOBOX PROTEIN; HOMEODOMAIN PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; DESMOPLASTIC SMALL ROUND CELL TUMOR; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; METASTASIS; NEOPLASM; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; RETINA TUMOR; RETINOBLASTOMA; RHABDOMYOSARCOMA;

DESMOPLASTIC SMALL ROUND CELL TUMOR; DIAGNOSIS, DIFFERENTIAL; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM METASTASIS; NEOPLASMS; NEUROBLASTOMA; NEUROECTODERMAL TUMORS, PRIMITIVE; RETINAL NEOPLASMS; RETINOBLASTOMA; RHABDOMYOSARCOMA; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 84863821558     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182601d84     Document Type: Article

References (11)

1. Glubrecht DD, Kim JH, Russell L, et al. Differential CRX and OTX2 expression in human retina and retinoblastoma. J Neurochem. 2009; 111:250-263.
2. Hsiau TH, Diaconu C, Myers CA, et al. The cis-regulatory logic of the mammalian photoreceptor transcriptional network. PLoS One. 2007;2:e643.
3. Santagata S, Maire CL, Idbaih A, et al. CRX is a diagnostic marker of retinal and pineal lineage tumors. PLoS One. 2009;4:e7932.
4. Castelino-Prabhu S, Stoll LM, Li QK. Metastatic retinoblastoma presenting as a left shoulder soft tissue mass: FNA findings and review of the literature. Diagn Cytopathol. 2010;38:440-446.
5. Cozza R, De Ioris MA, Ilari I, et al. Metastatic retinoblastoma: single institution experience over two decades. Br J Ophthalmol. 2009;93:1163-1166.
6. Mulligan ME, Smith SE, McCarthy EF Jr. Isolated lower extremity metastases, 9 years after initial diagnosis of retinoblastoma. Skeletal Radiol. 2006;35:774-777. (Pubitemid 44317530)
7. Kim JW, Kathpalia V, Dunkel IJ, et al. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93:463-467.
8. Gunduz K, Muftuoglu O, Gunalp I, et al. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology. 2006;113:1558-1566. (Pubitemid 44292302)
9. Leal-Leal CA, Rivera-Luna R, Flores-Rojo M, et al. Survival in extra-orbital metastatic retinoblastoma: treatment results. Clin Transl Oncol. 2006;8:39-44.
10. Kleinerman RA, Tucker MA, Abramson DH, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst. 2007;99:24-31.
11. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005;23:2272-2279. (Pubitemid 46218720)